Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891403026> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- W2891403026 abstract "Abstract Background The neoadjuvant chemotherapy using CDDP and 5-FU(CF) is the standard treatment for advanced esophageal cancer, defined as clinical stage II/III in Japan. However, more powerful chemotherapy has been required for the treatment of cases of cStageIII cases. In 2011, the combination treatment of CF and Docetaxel (DCF) was introduced for the treatment of those cases in our institute. DCF therapy increased chemotherapy remarkable cases. But, adverse events occur at high rates, including high myelosuppression. Therefore, it is necessary to ensure support by early intervention of supportive therapy so as not to exacerbate adverse events. We report about treatment outcome in preoperative DCF therapy cases. Methods We treated 128 esophageal cancer patients who underwent surgery following preoperative DCF therapy between 2011 and July 2017, and preoperative DCF was administered to 128 patients 2 course completely. The neoadjuvant chemotherapy regimen using DCF is Docetaxel:70mg/m2 (day1) + CDDP:70mg/m2 (day1) + 5-FU:700mg/m2 (day1–5). Results In the preoperative DCF group, overall response rate (over PR) was 51.5%. There were 37 cases in 128 cases of pathological tissue effect judgment for Grade 2 and 3. 14 cases of them (14cases/37cases:37.8%) had lymph node metastasis. Therefore it is necessary to control lymph node metastasis by surgery even in a remarkable group. Almost all patients experienced grade 4 adverse events, particularly neutropenia is a high frequency. From the start of chemotherapy, pretreatment of intraoral infection lesion and prevention and treatment of oral mucositis are performed. Considering the degree of myelosuppression during initial chemotherapy, in the second course, we actively administer G-CSF preparation. Conclusion A good prognosis can be expected if preoperative DCF therapy is effective. It is necessary to perform intensive and safe preoperative chemotherapy with appropriate supportive therapy intervention. Disclosure All authors have declared no conflicts of interest." @default.
- W2891403026 created "2018-09-27" @default.
- W2891403026 creator A5027121695 @default.
- W2891403026 creator A5055129091 @default.
- W2891403026 creator A5068717107 @default.
- W2891403026 creator A5071422219 @default.
- W2891403026 creator A5076268036 @default.
- W2891403026 creator A5091708188 @default.
- W2891403026 date "2018-09-01" @default.
- W2891403026 modified "2023-09-25" @default.
- W2891403026 title "PS02.101: PREOPERATIVE TREATMENT BASED ON THE DCF CHEMOTHERAPY AND SUPPORTIVE THERAPY FOR ESOPHAGEAL CANCER" @default.
- W2891403026 doi "https://doi.org/10.1093/dote/doy089.ps02.101" @default.
- W2891403026 hasPublicationYear "2018" @default.
- W2891403026 type Work @default.
- W2891403026 sameAs 2891403026 @default.
- W2891403026 citedByCount "0" @default.
- W2891403026 crossrefType "journal-article" @default.
- W2891403026 hasAuthorship W2891403026A5027121695 @default.
- W2891403026 hasAuthorship W2891403026A5055129091 @default.
- W2891403026 hasAuthorship W2891403026A5068717107 @default.
- W2891403026 hasAuthorship W2891403026A5071422219 @default.
- W2891403026 hasAuthorship W2891403026A5076268036 @default.
- W2891403026 hasAuthorship W2891403026A5091708188 @default.
- W2891403026 hasConcept C121608353 @default.
- W2891403026 hasConcept C126322002 @default.
- W2891403026 hasConcept C143998085 @default.
- W2891403026 hasConcept C2776694085 @default.
- W2891403026 hasConcept C2779742542 @default.
- W2891403026 hasConcept C61434518 @default.
- W2891403026 hasConcept C71924100 @default.
- W2891403026 hasConceptScore W2891403026C121608353 @default.
- W2891403026 hasConceptScore W2891403026C126322002 @default.
- W2891403026 hasConceptScore W2891403026C143998085 @default.
- W2891403026 hasConceptScore W2891403026C2776694085 @default.
- W2891403026 hasConceptScore W2891403026C2779742542 @default.
- W2891403026 hasConceptScore W2891403026C61434518 @default.
- W2891403026 hasConceptScore W2891403026C71924100 @default.
- W2891403026 hasLocation W28914030261 @default.
- W2891403026 hasOpenAccess W2891403026 @default.
- W2891403026 hasPrimaryLocation W28914030261 @default.
- W2891403026 isParatext "false" @default.
- W2891403026 isRetracted "false" @default.
- W2891403026 magId "2891403026" @default.
- W2891403026 workType "article" @default.